11/14/2024
5:23 PM | Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G | |
11/14/2024
4:21 PM | Almenoff June Sherie (Reporting)
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
11:05 AM | Allostery Investments LP (Filed by)
Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
| Form SC 13G/A | |
11/12/2024
6:30 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
4:00 PM | Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
Crutcher Patrick J (Filed by)
| Form SC 13G/A | |
11/07/2024
6:20 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/07/2024
6:02 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
11/07/2024
6:04 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
6:17 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/08/2024
6:13 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/07/2024
7:06 PM | Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
Ikarian Capital, LLC (Filed by)
| Form SC 13G | |
09/09/2024
6:22 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/04/2024
6:01 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/23/2024
3:34 PM | Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
| Form SC 13G | |
08/23/2024
3:16 PM | Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
08/14/2024
3:47 PM | Almenoff June Sherie (Reporting)
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
3:36 PM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
KANTOFF AARON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
3:27 PM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Truex Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
6:01 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
6:03 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/05/2024
11:15 PM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form EFFECT | |
07/16/2024
3:17 PM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Doyle Mittie (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/16/2024
3:23 PM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Doyle Mittie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
6:36 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2024
3:24 PM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form S-3/A | |
07/09/2024
6:17 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2024
6:04 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form ARS | |
06/27/2024
6:01 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form DEF 14A | |
06/27/2024
6:03 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form DEFA14A | |
06/24/2024
6:14 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
6:01 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form PRE 14A | |
06/03/2024
6:20 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K/A | |
05/13/2024
11:38 AM | Allostery Investments LP (Filed by)
Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
| Form SC 13G | |
05/13/2024
6:30 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
6:33 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/23/2024
1:59 PM | Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
Emerald Bioventures, LLC (Filed by)
| Form SC 13G | |
04/09/2024
3:58 PM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
03/28/2024
5:26 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form DEFA14A | |
03/28/2024
5:08 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
8:13 PM | Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024
3:36 PM | Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
GREAT POINT PARTNERS LLC (Filed by)
| Form SC 13G/A | |
Financial Prophecy (Ad) The Magnificent 7 could be in for a world of pain…
And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock.
The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on.
It’s called The Final Frontier. Including the name of the #1 company to buy. |
12/28/2023
4:05 PM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/07/2023
6:01 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/07/2023
6:02 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form DEFA14A | |
